IMCR in the 13F filings
Immunocore HLDGS PLC · CUSIP 45258D105
- Quarter end
- 30 Sep 2024
- the date the book describes
- Filed
- 14 Nov 2024
- latest of these filings; the earliest 13 Nov 2024
- Managers listing it
- 4
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q2 2024 and Q3 2024; 4 listed it in both
- Shares listed
- 8,328,514
- combined, among listed positions
- Reported value
- $259m
- combined, at the quarter end
Among the 94 comparable managers: 4 buyers (opened or added shares) and 0 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,023,346.
Managers listing IMCR in Q3 2024
4 of 4 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Wellington Management Group LLP | 7,048,833 | $219m | under 0.1% | Added | +668,382 | 14 Nov 2024 (the filing on sec.gov) |
| Two Sigma Advisers LP | 757,700 | $24m | 0.06% | Added | +300,200 | 14 Nov 2024 (the filing on sec.gov) |
| Woodline Partners LP | 274,681 | $8.6m | 0.07% | Added | +643 | 14 Nov 2024 (the filing on sec.gov) |
| Hudson Bay Capital Management LP | 247,300 | $7.7m | under 0.1% | Added | +54,121 | 13 Nov 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Wellington Management Group LLPexisting position · 7,048,833 shares now+668,382
- Two Sigma Advisers LPexisting position · 757,700 shares now+300,200
- Hudson Bay Capital Management LPexisting position · 247,300 shares now+54,121
- Woodline Partners LPexisting position · 274,681 shares now+643
Reductions
No reduction among listed positions.
New positions and exits
New (0)
No new position among listed positions.
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2021 | 2 | $5.9m | n.a. | n.a. |
| Q2 2021 | 1 | $5.4m | n.a. | n.a. |
| Q1 2022 | 1 | $12m | n.a. | n.a. |
| Q3 2022 | 2 | $32m | n.a. | n.a. |
| Q4 2022 | 4 | $181m | n.a. | n.a. |
| Q1 2023 | 2 | $203m | n.a. | n.a. |
| Q2 2023 | 4 | $416m | n.a. | n.a. |
| Q3 2023 | 5 | $353m | n.a. | n.a. |
| Q4 2023 | 4 | $511m | 3 | 1 |
| Q1 2024 | 6 | $609m | 4 | 1 |
| Q2 2024 | 4 | $248m | 3 | 1 |
| Q3 2024 | 4 | $259m | 4 | 0 |
| Q4 2024 | 4 | $232m | 2 | 2 |
| Q1 2025 | 5 | $238m | 3 | 2 |
| Q2 2025 | 5 | $193m | 1 | 4 |
| Q3 2025 | 4 | $205m | 1 | 3 |
| Q4 2025 | 5 | $214m | 16 | 8 |
| Q1 2026 | 4 | $182m | 19 | 8 |
| Q2 2026 | 4 | $248m | 15 | 10 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
IMCR and GILD →IMCR and AMGN →IMCR and ARGX →Choose a stock to compare with IMCR →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own IMCR, latest filings →Back to the 13F Explorer →